More Stories

Cardiology July 1, 2024

Cardiology in H1 2024 July 1, 2024

The first half of 2024 is now a wrap, and it was another big one in cardiology. Here are some of Cardiac Wire’s top six storylines from the last six months, plus some things to keep in mind as we head into 2024’s second half.

Surgeries & Interventions June 27, 2024

Shockwave Therapy’s Ischemic Heart Failure Potential June 27, 2024

New research out of Austria suggests that cardiac shockwave therapy could help address ischemic heart failure patients’ myocardial regeneration challenges, allowing meaningful LVEF and quality of life improvements, and potentially better outcomes.

Artificial Intelligence June 24, 2024

New Echo AI Model Could Streamline Mitral Regurgitation Diagnosis June 24, 2024

Columbia and Cornell researchers developed an echo AI model that could improve the difficult task of mitral regurgitation diagnosis, and might even represent an AI-driven step towards enhancing all valvular regurgitation assessments.

Pharmaceuticals June 20, 2024

Marea Therapeutics’ Cardiometabolic Mission June 20, 2024

Marea Therapeutics emerged this week, announcing $190M in Series A/B funding and a mission to develop "a new generation of medicines for cardiometabolic diseases" - starting with their drug candidate targeting remnant cholesterol.

Cardiology Practices June 17, 2024

The Rise of Private Equity Cardiology Practice Acquisitions June 17, 2024

New research in JAMA highlighted the rapid growth of private equity-backed cardiology practice acquisitions, while revealing some interesting geographic factors driving this growth.

Preventive Cardiology June 13, 2024

New Calculations Could Slash Statin-Eligible Population June 13, 2024

A JAMA paper suggests that if the CVD guidelines adopt the AHA’s new PREVENT cardiovascular risk equations, it might slash the US’s eligible preventive statin user population by nearly 40%.

Get twice-weekly insights on the biggest stories shaping cardiology.

You might also like..

Select All

You're signed up!

It's great to have you as a reader. Check your inbox for a welcome email.

-- The Cardiac Wire Team

You're all set!